How and where to order Robaxin (Methocarbamol) 500 mg tablets or capsules online on Pain Killer Abuse website:
|Prices:||from $0.36 per pill
|Discount:||10% coupon: DFHDCC
|Forms:||Methocarbamol (Robaxin) 500 mg capsules or tablets
|Type:||Methocarbamol brand, Robaxin generic
|Payment:||PayPal, Visa, MasterCard, AmEx, E-Check (ACH), Bitcoin
|Delivery:||Regular and express mail service
|Shipping:||Worldwide, including USA, UK, Europe, Canada, Australia
Methocarbamol (trade names include Robaxin, Bigomet, Carbamol, DoloVisano, Lumirelax, Myomethol, Ortoton, Rexivin, Robaxin-V, Robinax) is a muscle relaxant from carbamic acid esters pharmacological group. It is indicated together with rest, physical therapy, and other pain medications to treat skeletal muscle conditions such as pain, injury, skeletal muscle spasms, acute musculoskeletal spasms, painful musculoskeletal spasms, short-term musculoskeletal pain, muscle spasms associated with rib fractures, low back pain, neck pain, traumatic pain, dorsalgia, myalgia, rheumatoid arthritis, chronic neurological disorders, dyskinesias, cerebral palsy, to control neuromuscular spasms of tetanus. This medication is used also in veterinary. Methocarbamol works by blocking nerve impulses (or pain sensations) that are sent to patient's brain. Robaxin is one of the best to stop painful nerve impulses that control pain, to provide quick relief from muscle and back aches.
Acetaminophen, Methocarbamol (Robinaxol)
Probenecid (Benemid, Probalan)
Pharmacological and medical categories:
Carbonic anhydrase inhibitors
Pain relief drugs
Skeletal muscle relaxants
Veterinary, pet meds
M - Musculo-skeletal system
M03 - Muscle relaxants
M03B - Muscle relaxants, centrally acting agents
M03BA - Carbamic acid esters
M03BA03 - Methocarbamol
Other tetanus - A35
Dystonia - G24
Drug induced subacute dyskinesia - G24.01
Cerebral palsy - G80
Pain, not elsewhere classified - G89
Acute pain due to trauma - G89.11
Other disorders of central nervous system - G96
Other rheumatoid arthritis - M06
Dorsalgia - M54
Cervicalgia - M54.2
Low back pain - M54.5
Other disorders of muscle - M62
Muscle spasm of back - M62.830
Other muscle spasm - M62.838
Other and unspecified soft tissue disorders, not elsewhere classified - M79
Myalgia - M79.1
Injury, poisoning and certain other consequences of external causes - S00-T88
Injury of muscle and tendon at hip and thigh level - S76
Indications and usage:
Robaxin (Methocarbamol) 500 mg and 750 mg tablets are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of methocarbamol has not been clearly identified, but may be related to its sedative properties. Methocarbamol does not directly relax tense skeletal muscles in man.
Dosage and administration:
Robaxin (Methocarbamol) 500 mg for adults
Initial dosage: 3 tablets q.i.d.
Maintenance dosage: 2 tablets q.i.d.
Robaxin-750 (Methocarbamol) 750 mg for adults
Initial dosage: 2 tablets q.i.d.
Maintenance dosage: 1 tablet q.4h. or 2 tablets t.i.d.
Six grams a day are recommended for the first 48 to 72 hours of treatment. (For severe conditions 8 grams a day may be administered). Thereafter, the dosage can usually be reduced to approximately 4 grams a day.
Limited information is available on the acute toxicity of methocarbamol. Overdose of Robaxin is frequently in conjunction with alcohol or other CNS depressants and includes the following symptoms: nausea, drowsiness, blurred vision, hypotension, seizures, and coma. In post-marketing experience, deaths have been reported with an overdose of methocarbamol alone or in the presence of other CNS depressants, alcohol or psychotropic drugs.
Management of overdose includes symptomatic and supportive treatment. Supportive measures include maintenance of an adequate airway, monitoring urinary output and vital signs, and administration of intravenous fluids if necessary. The usefulness of hemodialysis in managing overdose is unknown.
Robaxin (Methocarbamol) tablets are contraindicated in patients hypersensitive to methocarbamol or to any of the tablet components.
Since methocarbamol may possess a general CNS depressant effect, patients receiving Robaxin should be cautioned about combined effects with alcohol and other CNS depressants. Safe use of Methocarbamol (Robaxin) pills has not been established with regard to possible adverse effects upon fetal development. There have been reports of fetal and congenital abnormalities following in utero exposure to methocarbamol. Therefore, Robaxin should not be used in women who are or may become pregnant and particularly during early pregnancy unless in the judgment of the physician the potential benefits outweigh the possible hazards.
Use in activities requiring mental alertness
Methocarbamol may impair mental and/or physical abilities required for performance of hazardous tasks, such as operating machinery or driving a motor vehicle. Patients should be cautioned about operating machinery, including automobiles, until they are reasonably certain that methocarbamol therapy does not adversely affect their ability to engage in such activities.
Drug/laboratory test interactions
Methocarbamol may cause a color interference in certain screening tests for 5-hydroxyindoleacetic acid (5-HIAA) using nitrosonaphthol reagent and in screening tests for urinary vanillylmandelic acid (VMA) using the Gitlow method.
Carcinogenesis, mutagenesis, impairment of fertility
Long-term studies to evaluate the carcinogenic potential of methocarbamol have not been performed. No studies have been conducted to assess the effect of Methocarbamol (Robaxin) on mutagenesis or its potential to impair fertility.
Adverse reactions, side effects:
Adverse reactions reported coincident with the administration of methocarbamol include:
Body as a whole: anaphylactic reaction, angioneurotic edema, fever, headache.
Cardiovascular system: bradycardia, flushing, hypotension, syncope, thrombophlebitis.
Digestive system: dyspepsia, jaundice (including cholestatic jaundice), nausea and vomiting.
Hemic and lymphatic system: leukopenia.
Immune system: hypersensitivity reactions.
Nervous system: amnesia, confusion, diplopia, dizziness or lightheadedness, drowsiness, insomnia, mild muscular incoordination, nystagmus, sedation, seizures (including grand mal), vertigo.
Skin and special senses: blurred vision, conjunctivitis, nasal congestion, metallic taste, pruritus, rash, urticaria.
Methocarbamol may inhibit the effect of pyridostigmine bromide. Therefore, methocarbamol should be used with caution in patients with myasthenia gravis receiving anticholinesterase agents.
Use in specific populations:
Teratogenic effects. Pregnancy Category C. Animal reproduction studies have not been conducted with methocarbamol. It is also not known whether methocarbamol can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Robaxin should be given to a pregnant woman only if clearly needed.
Safe use of Robaxin has not been established with regard to possible adverse effects upon fetal development. There have been reports of fetal and congenital abnormalities following in utero exposure to methocarbamol. Therefore, this medication should not be used in women who are or may become pregnant and particularly during early pregnancy unless in the judgment of the physician the potential benefits outweigh the possible hazards.
Methocarbamol and/or its metabolites are excreted in the milk of dogs; however, it is not known whether methocarbamol or its metabolites are excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Robaxin is administered to a nursing woman.
Safety and effectiveness of Robaxin in pediatric patients below the age of 16 have not been established.
Information for patients:
Patients should be cautioned that methocarbamol may cause drowsiness or dizziness, which mayimpair their ability to operate motor vehicles or machinery.
Because methocarbamol may possess a general CNS-depressant effect, patients should be cautioned about combined effects with alcohol and other CNS depressants.
B2 - Australia
C - United States (Risk cannot be ruled out)
Salts and other forms:
Synonyms, international and chemical names:
1,2-Propanediol, 3-(o-methoxyphenoxy)-, 1-carbamate
Carbamic Acid, 2-Hydroxy-3-(o-methoxyphenoxy)Propyl Ester
Guaiacol Glyceryl Ether Carbamate
Guiacol Gliceriletere Monocarbammato
Brands, generics, trade names:
Bigomet - Aristo Pharmaceuticals
Carbamol - Sinil Pharmaceutical
Corexin - Hankook Korus Pharm
DoloVisano - Dr. Kade
Lumirelax - Tradiphar Laboratoire, Alpharma, Juvise Pharmaceuticals Laboratories
Methocarbamol - APP Pharmaceuticals, Lannett, Mylan, Recordati, Sandoz, Watson Pharmaceuticals
Methoxine - Kyung Dong Pharmaceutical
Metocarbamol - Anglopharma, Bussie Laboratorios, Pharmeuropea
Metocarban - Industria Farmaceutica
Mioflex - Labinco
Myomethol - R.X. Company, AustraPharm
Ortoton - Bastian-Werk, Recordati
Rexivin - Collins Productos Farmaceuticos
Robaxin - Pfizer, Actient Pharmaceuticals
Robaxin-V - Pfizer, Bayer, Zoetis
Robinax - Khandelwal Laboratories
APIs used in medicine in combinations with methocarbamol:
Here is a list of popular medications containing methocarbamol as a main active pharmaceutical ingredient; their trade names, forms, doses, companies - manufacturers, distributors, suppliers, researchers and developers:
|Trade name of the drug
||Pharmaceutical forms and doses
||Tablets; Oral; Methocarbamol 250 mgTablets; Oral; Methocarbamol 500 mgTablets; Oral; Methocarbamol 750 mg
||Aristo PharmaceuticalsOtsira Genetica
||Cream; Topical; Methocarbamol 10%Tabsule; Oral; Methocarbamol 500 mg
||Tradiphar LaboratoireAlpharmaJuvise Pharmaceuticals Laboratories
||Tablets; Oral; Methocarbamol 500 mg
||R.X. CompanyAustraPharmHind WingMedi Myanmar GroupMinh Tien Pharmaceutical
||Tablets, Film-Coated; Oral; Methocarbamol 750 mg
||Granules for Solution; Oral; Methocarbamol 900 mg / gInjectable; Injection; Methocarbamol 100 mg / mlTablets; Oral; Methocarbamol 500 mgTablets; Oral; Methocarbamol 750 mg
||PfizerActient PharmaceuticalsAlmirallASKA PharmaceuticalAspen PharmacareAuxilium PharmaceuticalsBaxterFaes FarmaIpsen PharmaSchwarz PharmaShireU.S. SummitWest-Ward PharmaceuticalsWyeth
||Injectable; Injection; Methocarbamol 100 mg / mlTablets; Oral; Methocarbamol 500 mg
||Khandelwal LaboratoriesNi Lay NaingXenon Pharmaceuticals
Methocarbamol main article on Wikipedia: https://en.wikipedia.org/wiki/Methocarbamol
Methocarbamol compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/METHOCARBAMOL
Methocarbamol on DrugBank: https://go.drugbank.com/drugs/DB00423
Methocarbamol FAQ on MedlinePlus (revised 08/15/2017): https://medlineplus.gov/druginfo/meds/a682579.html
Medicines for back pain FAQ on MedlinePlus: https://medlineplus.gov/ency/article/007486.htm
Robaxin (Methocarbamol) tablets film-coated drug label info on DailyMed (revised May 18, 2016): https://dailymed.nlm.nih.gov/dailymed/drugInfo...
Robaxin (Methocarbamol) injection drug label info on DailyMed (revised December 10, 2018): https://dailymed.nlm.nih.gov/dailymed/drugInfo...
Methocarbamol tablets drug label info on DailyMed (revised July 2, 2020): https://dailymed.nlm.nih.gov/dailymed/drugInfo...
Methocarbamol containing drugs on Drugs-About.com: https://drugs-about.com/ing/methocarbamol.html
Methocarbamol for sale on Pharma Doctor: https://pharma-doctor.com/methocarbamol.html
Methocarbamol international drug names on Drugs.com: https://www.drugs.com/international/methocarbamol.html
Robaxin (Methocarbamol) 500 mg, 750 mg tablets official prescribing information from the U.S. FDA (revised 02/2003): https://www.accessdata.fda.gov/drugsatfda_docs/label...
Robaxin Injectable (Methocarbamol injection, USP) official prescribing information from the U.S. FDA (revised November 2003): https://www.accessdata.fda.gov/drugsatfda_docs/label...
Robaxin (Methocarbamol) 750 mg tablets prescribing information from Endo Pharmaceuticals (revised 01/2019): https://www.endo.com/File%20Library/Products/...
Robaxin (Methocarbamol) consumer information from RxList (revised 10/15/2020): https://www.rxlist.com/robaxin-drug/patient-images-side-effects.htm
Methocarbamol drug summary on information on PDR: https://www.pdr.net/drug-summary/Robaxin...
Veterinarian Robaxin-V (Methocarbamol) injectable and tablets prescribing information from Zoetis pharmaceutical company (revised October 2003): https://www.zoetisus.com/_locale-assets/mcm-portal-assets/...
Robaxin-750 (Methocarbamol) 750 mg film-coated tablets patient information leaflet on Medicines.org.uk (revised September 2018): https://www.medicines.org.uk/emc/files/pil.440.pdf
Revised: May 2021
Home | Painkiller Abuse Dangers | Painkiller Abuse Facts | Painkiller Abuse Support | Painkiller Abuse Treatment | Painkiller Abuse Withdrawal Symptoms | Signs of Painkiller Abuse
Copyright © 2012 - 2021 Pain Killer Abuse. All rights reserved.